These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 19642533)

  • 1. [The role of taxanes in breast cancer chemotherapy: what's new 15 years after?].
    Herceg D; Vrbanec D
    Lijec Vjesn; 2009; 131(5-6):133-41. PubMed ID: 19642533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.
    Piccart-Gebhart MJ; Burzykowski T; Buyse M; Sledge G; Carmichael J; Lück HJ; Mackey JR; Nabholtz JM; Paridaens R; Biganzoli L; Jassem J; Bontenbal M; Bonneterre J; Chan S; Basaran GA; Therasse P
    J Clin Oncol; 2008 Apr; 26(12):1980-6. PubMed ID: 18421049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current trends in pharmacotherapy of breast cancer].
    Boér K
    Orv Hetil; 2002 Apr; 143(14):725-30. PubMed ID: 11975393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based use of taxanes in the adjuvant setting of breast cancer. A review of randomized phase III trials.
    Estévez LG; Muñoz M; Alvarez I; Fernández Y; García-Mata J; Ruiz-Borrego M; Tusquets I; Seguí MA; Rodríguez-Lescure A; Adrover E; Lluch A
    Cancer Treat Rev; 2007 Aug; 33(5):474-83. PubMed ID: 17561350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant taxanes: more to the story.
    Gajria D; Seidman A; Dang C
    Clin Breast Cancer; 2010 Sep; 10 Suppl 2():S41-9. PubMed ID: 20805064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.
    Vici P; Viola G; Rossi S; Botti C; Vitucci C; Sergi D; Ferranti FR; Saracca E; Di Lauro L; Corsetti S; Foggi P; Fattoruso SI; Lopez M
    Clin Ter; 2008; 159(6):453-6. PubMed ID: 19169608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taxanes in the adjuvant treatment of early breast cancer, emerging consensus and unanswered questions.
    Tang SC
    Cancer Invest; 2009 Jun; 27(5):489-95. PubMed ID: 19479486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxanes as primary chemotherapy for early breast cancer: meta-analysis of randomized trials.
    Cuppone F; Bria E; Carlini P; Milella M; Felici A; Sperduti I; Nisticò C; Terzoli E; Cognetti F; Giannarelli D
    Cancer; 2008 Jul; 113(2):238-46. PubMed ID: 18470908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
    Sparano JA
    Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug treatments for adjuvant chemotherapy in breast cancer: recent trials and future directions.
    Dang CT
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):427-36. PubMed ID: 16503859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined anthracycline-taxane regimens in the adjuvant setting.
    Mamounas EP; Sledge GW
    Semin Oncol; 2001 Aug; 28(4 Suppl 12):24-31. PubMed ID: 11552227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment: the effect of the addition of taxanes.
    Davis AL; Klitus M; Mintzer DM
    Clin Breast Cancer; 2005 Dec; 6(5):421-4. PubMed ID: 16381625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes.
    Tanabe M; Ito Y; Tokudome N; Sugihara T; Miura H; Takahashi S; Seto Y; Iwase T; Hatake K
    Breast Cancer; 2009; 16(4):301-6. PubMed ID: 19205831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
    Moreno-Aspitia A; Perez EA
    Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Taxanes in neojuvant radio-, chemoradio- and chemotherapy for breast cancer].
    Bozhok AA; Semiglazov VF; Kletzel' AE; Arzumanov AS; Mel'nikova OA; Paltuev RM; Ivanova OA; Semiglazov VV
    Vopr Onkol; 2006; 52(1):7-14. PubMed ID: 16715697
    [No Abstract]   [Full Text] [Related]  

  • 17. Taxanes in the treatment of early breast cancer.
    Ring AE; Ellis PA
    Cancer Treat Rev; 2005 Dec; 31(8):618-27. PubMed ID: 16266787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit from adjuvant taxanes and endocrine responsiveness in breast cancer.
    Martin M; Mackey J; Vogel C
    Breast; 2007 Dec; 16 Suppl 2():S127-31. PubMed ID: 17923408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer.
    Bedard PL; Di Leo A; Piccart-Gebhart MJ
    Nat Rev Clin Oncol; 2010 Jan; 7(1):22-36. PubMed ID: 19997076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant taxanes in the treatment of breast cancer: no longer at the tip of the iceberg.
    Dang C; Hudis C
    Clin Breast Cancer; 2006 Apr; 7(1):51-8. PubMed ID: 16764744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.